These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19746273)

  • 1. [Cystatin C and adiponectin in diabetics with and without coronary artery disease].
    Wolff C; Durruty P; Espinoza J; Ripamonti S; Díaz J
    Rev Med Chil; 2009 Jun; 137(6):729-36. PubMed ID: 19746273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
    Maahs DM; Ogden LG; Kretowski A; Snell-Bergeon JK; Kinney GL; Berl T; Rewers M
    Diabetes; 2007 Nov; 56(11):2774-9. PubMed ID: 17660266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
    Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M
    Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of cystatin C and transforming growth factor-beta1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-beta1.
    Yetkin E; Acikgoz N; Sivri N; Tekin GO; Yagmur J; Aksoy Y; Turhan H
    Coron Artery Dis; 2007 May; 18(3):211-4. PubMed ID: 17429295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
    Yaturu S; Daberry RP; Rains J; Jain S
    Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
    Ezenwaka CE; Kalloo R
    Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2005 Feb; 108(2):121-8. PubMed ID: 15504106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of plasma adiponectin in prediabetes, Type 2 diabetes and coronary artery disease.
    Yaturu S; Bridges JF; Subba Reddy DR
    Med Sci Monit; 2006 Jan; 12(1):CR17-20. PubMed ID: 16369465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
    Dzielinska Z; Januszewicz A; Wiecek A; Prejbisz A; Zielinski T; Chudek J; Makowiecka-Ciesla M; Demkow M; Tyczynski P; Januszewicz M; Ruzyllo W; Naruszewicz M
    Kidney Blood Press Res; 2010; 33(2):139-48. PubMed ID: 20516698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Baumert J; Meisinger C; Löwel H
    J Am Coll Cardiol; 2006 Oct; 48(7):1369-77. PubMed ID: 17010797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin--its potential to predict and prevent coronary artery disease.
    Skrabal CA; Czaja J; Honz K; Emini R; Hannekum A; Friedl R
    Thorac Cardiovasc Surg; 2011 Jun; 59(4):201-6. PubMed ID: 21416461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus.
    Endo K; Oyama T; Saiki A; Ban N; Ohira M; Koide N; Murano T; Watanabe H; Nishii M; Miura M; Sekine K; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2008 Apr; 80(1):63-8. PubMed ID: 18207277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
    Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
    Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.